Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA’s Hamburg Seeks Leeway From Congress on Biologics
FDA’s Hamburg Seeks Leeway From Congress on Biologics
FDA’s Hamburg Seeks Leeway From Congress on Biologics
Submitted by
admin
on July 17, 2009 - 8:04am
Source:
Bloomberg
News Tags:
FDA
healthcare reform
generics
Peggy Hamburg
biologics
Headline:
FDA’s Hamburg Seeks Leeway From Congress on Biologics
Do Not Allow Advertisers to Use My Personal information
